(Q57626635)

21

0 references

Gregory Lip

22

object named as

G. Y. H. Lip

0 references

author name string

C. T. Pedersen

1

0 references

G. N. Kay

2

0 references

J. Kalman

3

0 references

M. Borggrefe

4

0 references

P. Della-Bella

5

0 references

T. Dickfeld

6

0 references

P. Dorian

7

0 references

H. Huikuri

8

0 references

Y.-H. Kim

9

0 references

B. Knight

10

0 references

F. Marchlinski

11

0 references

D. Ross

12

0 references

F. Sacher

13

0 references

J. Sapp

14

0 references

K. Soejima

16

0 references

H. Tada

17

0 references

M. E. Alexander

18

0 references

J. K. Triedman

19

0 references

T. Yamada

20

0 references

K. H. Kuck

23

0 references

L. Mont

24

0 references

D. Haines

25

0 references

J. Indik

26

0 references

J. Dimarco

27

0 references

D. Exner

28

0 references

Y. Iesaka

29

0 references

I. Savelieva

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Gui

30

0 references

publication date

29 August 2014

0 references

published in

EP Europace

0 references

volume

16

0 references

page(s)

1257-1283

0 references

issue

9

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias: developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (H

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

A practical guide for clinicians who treat patients with amiodarone: 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Management of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Guidelines for the diagnosis and management of syncope (version 2009)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

The prognostic significance of premature ventricular complexes in adults without clinically apparent heart disease: a meta-analysis and systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular Premature Beats and Mortality after Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Asymptomatic ventricular arrhythmias and mortility risk in subjects withs with left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Reversal of outflow tract ventricular premature depolarization-induced cardiomyopathy with ablation: effect of residual arrhythmia burden and preexisting cardiomyopathy on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Characteristics of premature ventricular complexes as correlates of reduced left ventricular systolic function: study of the burden, duration, coupling interval, morphology and site of origin of PVCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Tachycardia-induced cardiomyopathy in patients with idiopathic ventricular arrhythmias: the incidence, clinical and electrophysiologic characteristics, and the predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: utility for identifying the ventricular arrhythmia substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prognostic significance of frequent premature ventricular contractions originating from the ventricular outflow tract in patients with normal left ventricular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Premature ventricular complexes in the absence of identifiable heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ablation of idiopathic right ventricular outflow tract tachycardia: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Idiopathic ventricular arrhythmias originating from the left ventricular summit: anatomic concepts relevant to ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of Valsalva: electrophysiological characteristics, catheter ablation, and identification from the 12-lead electrocardiogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Beneficial effects of catheter ablation on left ventricular and right ventricular function in patients with frequent premature ventricular contractions and preserved ejection fraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

The left ventricular ostium: an anatomic concept relevant to idiopathic ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

The V(2) transition ratio: a new electrocardiographic criterion for distinguishing left from right ventricular outflow tract tachycardia origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Nonsustained ventricular tachycardia: where do we stand?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Hear

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Relation between training-induced left ventricular hypertrophy and risk for ventricular tachyarrhythmias in elite athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Clinical and genetic determinants of torsade de pointes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prognostic importance of defibrillator shocks in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

What we have learned from the family of multicenter automatic defibrillator implantation trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Dev

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Arrhythmias originating from the right ventricular outflow tract: how to distinguish "malignant" from "benign"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

"Stable" ventricular tachycardia is not a benign rhythm : insights from the antiarrhythmics versus implantable defibrillators (AVID) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ablation or conservative management of electrical storm due to monomorphic ventricular tachycardia: differences in outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Application of a new algorithm in the differential diagnosis of wide QRS complex tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

New algorithm using only lead aVR for differential diagnosis of wide QRS complex tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Comparison of five electrocardiographic methods for differentiation of wide QRS-complex tachycardias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Automated analysis of the 12-lead electrocardiogram to identify the exit site of postinfarction ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Using the surface electrocardiogram to localize the origin of idiopathic ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Fragmented wide QRS on a 12-lead ECG: a sign of myocardial scar and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Cardiac MRI in the treatment of arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prognostic value of endocardial voltage mapping in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 G

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Diagnosis and management of idiopathic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Electrical storm: definitions, clinical importance, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prophylactic catheter ablation for the prevention of defibrillator therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Delayed enhancement magnetic resonance imaging in nonischemic myocardial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

The role of catheter ablation for ventricular tachycardia in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; th

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Brugada syndrome: report of the second consensus conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Effects of head-up tilt-table test on the QT interval.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular arrhythmias in the absence of structural heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Genetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Derivation and validation of a simple exercise-based algorithm for prediction of genetic testing in relatives of LQTS probands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Epinephrine QT stress testing in congenital long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Efficacy of quinidine in high-risk patients with Brugada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Long-term follow-up of patients with short QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mapping and ablation of idiopathic ventricular fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Catheter ablation of a polymorphic ventricular tachycardia inducing monofocal premature ventricular complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Endocardial versus epicardial ventricular radiofrequency ablation: utility of in vivo contact force assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: long-term outcome after ablation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Catheter ablation of electrical storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Neuraxial modulation for refractory ventricular arrhythmias: value of thoracic epidural anesthesia and surgical left cardiac sympathetic denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Incidence and clinical significance of short-term recurrent ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Long-term follow-up in patients with incessant ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Long-term temporal patterns of ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular arrhythmias after left ventricular assist device

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Effects of left ventricular assist device therapy on ventricular arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Epidemiology, management, and outcomes of sustained ventricular arrhythmias after continuous-flow left ventricular assist device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular arrhythmias during left ventricular assist device support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Use of a continuous-flow device in patients awaiting heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular arrhythmias after left ventricular assist device implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular arrhythmias in patients with implanted ventricular assist devices: a contemporary review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Endocardial catheter ablation of ventricular tachycardia in patients with ventricular assist devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Successful radiofrequency ablation therapy for intractable ventricular tachycardia with a ventricular assist device.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Robotic catheter ablation of left ventricular tachycardia: initial experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Concomitant left ventricular assist device placement and cryoablation for treatment of ventricular tachyarrhythmias associated with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Midterm results after the arterial switch operation for transposition of the great arteries with intact ventricular septum: clinical, hemodynamic, echocardiographic, and electrophysiologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Mortality in adult congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Value of programmed ventricular stimulation after tetralogy of fallot repair: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Programmed ventricular stimulation for risk stratification in patients with tetralogy of Fallot: a Bayesian perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular arrhythmias in postoperative tetralogy of Fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Adult congenital heart disease: toward prospective risk assessment of a multisystemic condition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Usefulness of cardiopulmonary exercise to predict long-term prognosis in adults with repaired tetralogy of Fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Microvolt t-wave alternans with exercise in pediatrics and congenital heart disease: limitations and predictive value

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Radiofrequency catheter ablation of right ventricular tachycardia late after repair of congenital heart defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Successful radiofrequency catheter ablation of left ventricular tachycardia following surgical correction of tetralogy of Fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Antitachycardia pacing reduces appropriate and inappropriate shocks in children and congenital heart disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Outcomes after late reoperation in patients with repaired tetralogy of Fallot: the impact of arrhythmia and arrhythmia surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

High Efficacy of β-Blockers in Long-QT Syndrome Type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Electrocardiographic Patterns of Superior Right Ventricular Outflow Tract Tachycardias: Distinguishing Septal and Free-Wall Sites of Origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Identification of distinct electrocardiographic patterns from the basal left ventricle: Distinguishing medial and lateral sites of origin in patients with idiopathic ventricular tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Electroanatomic Substrate and Ablation Outcome for Suspected Epicardial Ventricular Tachycardia in Left Ventricular Nonischemic Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Characterization of Endocardial Electrophysiological Substrate in Patients With Nonischemic Cardiomyopathy and Monomorphic Ventricular Tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

T WAVE ALTERNANS IN EXPERIMENTAL MYOCARDIAL INFARCTION: TIME COURSE AND PREDICTIVE VALUE FOR THE ASSESSING OF MYOCARDIAL DAMAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194

Systematic Assessment of Patients With Unexplained Cardiac Arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUU194